| Id |
Subject |
Object |
Predicate |
Lexical cue |
| TextSentencer_T1 |
0-154 |
Sentence |
denotes |
A novel pentaglycosylceramide in ostrich liver, IV4-beta-Gal-nLc4Cer, with terminal Gal(beta1-4)Gal, a xenoepitope recognized by human natural antibodies. |
| T1 |
0-154 |
Sentence |
denotes |
A novel pentaglycosylceramide in ostrich liver, IV4-beta-Gal-nLc4Cer, with terminal Gal(beta1-4)Gal, a xenoepitope recognized by human natural antibodies. |
| T1 |
0-154 |
Sentence |
denotes |
A novel pentaglycosylceramide in ostrich liver, IV4-beta-Gal-nLc4Cer, with terminal Gal(beta1-4)Gal, a xenoepitope recognized by human natural antibodies. |
| TextSentencer_T2 |
155-259 |
Sentence |
denotes |
Thin layer chromatograms of ostrich liver neutral glycosphingolipids were immunostained with human sera. |
| T2 |
155-259 |
Sentence |
denotes |
Thin layer chromatograms of ostrich liver neutral glycosphingolipids were immunostained with human sera. |
| T2 |
155-259 |
Sentence |
denotes |
Thin layer chromatograms of ostrich liver neutral glycosphingolipids were immunostained with human sera. |
| TextSentencer_T3 |
260-415 |
Sentence |
denotes |
In addition to the expected staining of the Forssman pentaglycosylceramide by some sera, more polar and less abundant unknown glycolipids could be stained. |
| T3 |
260-415 |
Sentence |
denotes |
In addition to the expected staining of the Forssman pentaglycosylceramide by some sera, more polar and less abundant unknown glycolipids could be stained. |
| T3 |
260-415 |
Sentence |
denotes |
In addition to the expected staining of the Forssman pentaglycosylceramide by some sera, more polar and less abundant unknown glycolipids could be stained. |
| TextSentencer_T4 |
416-573 |
Sentence |
denotes |
Among them, the shortest carbohydrate chain glycolipid was purified and structurally characterized by mass spectrometry, proton NMR and methylation analysis. |
| T4 |
416-573 |
Sentence |
denotes |
Among them, the shortest carbohydrate chain glycolipid was purified and structurally characterized by mass spectrometry, proton NMR and methylation analysis. |
| T4 |
416-573 |
Sentence |
denotes |
Among them, the shortest carbohydrate chain glycolipid was purified and structurally characterized by mass spectrometry, proton NMR and methylation analysis. |
| TextSentencer_T5 |
574-725 |
Sentence |
denotes |
It was a novel pentaglycosylceramide of the neolactoseries terminated with the Gal(beta1-4)Gal determinant which is not expressed in mammalian species. |
| T5 |
574-725 |
Sentence |
denotes |
It was a novel pentaglycosylceramide of the neolactoseries terminated with the Gal(beta1-4)Gal determinant which is not expressed in mammalian species. |
| T5 |
574-725 |
Sentence |
denotes |
It was a novel pentaglycosylceramide of the neolactoseries terminated with the Gal(beta1-4)Gal determinant which is not expressed in mammalian species. |
| TextSentencer_T6 |
726-949 |
Sentence |
denotes |
Human antibodies affinity-purified on a synthetic Gal(beta1-4)Gal(beta1-4)Glc-Sepharose column recognized the newly characterized Gal(beta1-4)Gal-terminated pentaglycosylceramide, and, in addition, longer chain glycolipids. |
| T6 |
726-949 |
Sentence |
denotes |
Human antibodies affinity-purified on a synthetic Gal(beta1-4)Gal(beta1-4)Glc-Sepharose column recognized the newly characterized Gal(beta1-4)Gal-terminated pentaglycosylceramide, and, in addition, longer chain glycolipids. |
| T6 |
726-949 |
Sentence |
denotes |
Human antibodies affinity-purified on a synthetic Gal(beta1-4)Gal(beta1-4)Glc-Sepharose column recognized the newly characterized Gal(beta1-4)Gal-terminated pentaglycosylceramide, and, in addition, longer chain glycolipids. |
| TextSentencer_T7 |
950-1054 |
Sentence |
denotes |
Occurrence of antibodies directed at the Gal(beta1-4)Gal epitope was studied by ELISA on 108 human sera. |
| T7 |
950-1054 |
Sentence |
denotes |
Occurrence of antibodies directed at the Gal(beta1-4)Gal epitope was studied by ELISA on 108 human sera. |
| T7 |
950-1054 |
Sentence |
denotes |
Occurrence of antibodies directed at the Gal(beta1-4)Gal epitope was studied by ELISA on 108 human sera. |
| TextSentencer_T8 |
1055-1303 |
Sentence |
denotes |
Anti-Gal(beta1-4)Gal antibodies were predominantly IgM, and their distribution was similar to that of anti-Gal(alpha1-3)Gal and anti-Forssman IgMs. It was concluded that anti-Gal(beta1-4)Gal are natural antibodies, not previously identified in man. |
| T8 |
1055-1303 |
Sentence |
denotes |
Anti-Gal(beta1-4)Gal antibodies were predominantly IgM, and their distribution was similar to that of anti-Gal(alpha1-3)Gal and anti-Forssman IgMs. It was concluded that anti-Gal(beta1-4)Gal are natural antibodies, not previously identified in man. |
| T8 |
1055-1303 |
Sentence |
denotes |
Anti-Gal(beta1-4)Gal antibodies were predominantly IgM, and their distribution was similar to that of anti-Gal(alpha1-3)Gal and anti-Forssman IgMs. It was concluded that anti-Gal(beta1-4)Gal are natural antibodies, not previously identified in man. |
| TextSentencer_T9 |
1304-1426 |
Sentence |
denotes |
They can be considered as xenoantibodies directed at species which express Gal(beta1-4)Gal-terminated carbohydrate chains. |
| T9 |
1304-1426 |
Sentence |
denotes |
They can be considered as xenoantibodies directed at species which express Gal(beta1-4)Gal-terminated carbohydrate chains. |
| T9 |
1304-1426 |
Sentence |
denotes |
They can be considered as xenoantibodies directed at species which express Gal(beta1-4)Gal-terminated carbohydrate chains. |